The finding that ACE inhibition therapy augmented the number of circulating EPCs in patients with CAD, and also enhanced EPCs functional activity, may provide a novel strategy to improve neovascularization and reendothelialization after ischemia, thereby providing a therapeutic concept to improve EPC numbers and functions in patients with CAD. Here, ACE is linked to coronary artery disorder.